{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:35:38Z","timestamp":1794580538407,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Grants-in-aid for Scientific Research, The Japan Society for the Promotion of Science"},{"name":"Grants for excellent Graduate Schools, the Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-1086-y","type":"journal-article","created":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T13:57:52Z","timestamp":1471442272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Interleukin-21 signaling in B cells, but not in T cells, is indispensable for the development of collagen-induced arthritis in mice"],"prefix":"10.1186","volume":"18","author":[{"given":"Koji","family":"Sakuraba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Oyamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanne","family":"Spolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihide","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren J.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunobu","family":"Yoshikai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6329-7222","authenticated-orcid":false,"given":"Hisakata","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,17]]},"reference":[{"key":"1086_CR1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrd4296","volume":"13","author":"R Spolski","year":"2014","unstructured":"Spolski R, Leonard WJ. Interleukin-21: a double-edged sword with therapeutic potential. Nat Rev Drug Discov. 2014;13:379\u201395.","journal-title":"Nat Rev Drug Discov"},{"key":"1086_CR2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature05970","volume":"448","author":"T Korn","year":"2007","unstructured":"Korn T, Bettelli E, Gao W, Awasthi A, Jager A, Strom TB, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 2007;448:484\u20137.","journal-title":"Nature"},{"key":"1086_CR3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature05969","volume":"448","author":"R Nurieva","year":"2007","unstructured":"Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 2007;448:480\u20133.","journal-title":"Nature"},{"key":"1086_CR4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.immuni.2008.05.009","volume":"29","author":"RI Nurieva","year":"2008","unstructured":"Nurieva RI, Chung Y, Hwang D, Yang XO, Kang HS, Ma L, et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity. 2008;29:138\u201349.","journal-title":"Immunity"},{"key":"1086_CR5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.20091738","volume":"207","author":"MA Linterman","year":"2010","unstructured":"Linterman MA, Beaton L, Yu D, Ramiscal RR, Srivastava M, Hogan JJ, et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J Exp Med. 2010;207:353\u201363.","journal-title":"J Exp Med"},{"key":"1086_CR6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.20091777","volume":"207","author":"D Zotos","year":"2010","unstructured":"Zotos D, Coquet JM, Zhang Y, Light A, D\u2019Costa K, Kallies A, et al. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J Exp Med. 2010;207:365\u201378.","journal-title":"J Exp Med"},{"key":"1086_CR7","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1077002","volume":"298","author":"K Ozaki","year":"2002","unstructured":"Ozaki K, Spolski R, Feng CG, Qi CF, Cheng J, Sher A, et al. A critical role for IL-21 in regulating immunoglobulin production. Science. 2002;298:1630\u20134.","journal-title":"Science"},{"key":"1086_CR8","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/art.20218","volume":"50","author":"A Jungel","year":"2004","unstructured":"Jungel A, Distler JH, Kurowska-Stolarska M, Seemayer CA, Seibl R, Forster A, et al. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum. 2004;50:1468\u201376.","journal-title":"Arthritis Rheum"},{"key":"1086_CR9","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3899\/jrheum.100259","volume":"37","author":"TK Rasmussen","year":"2010","unstructured":"Rasmussen TK, Andersen T, Hvid M, Hetland ML, Horslev-Petersen K, Stengaard-Pedersen K, et al. Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis. J Rheumatol. 2010;37:2014\u201320.","journal-title":"J Rheumatol"},{"key":"1086_CR10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.humimm.2010.01.010","volume":"71","author":"X Niu","year":"2010","unstructured":"Niu X, He D, Zhang X, Yue T, Li N, Zhang JZ, et al. IL-21 regulates Th17 cells in rheumatoid arthritis. Hum Immunol. 2010;71:334\u201341.","journal-title":"Hum Immunol"},{"key":"1086_CR11","doi-asserted-by":"crossref","first-page":"R255","DOI":"10.1186\/ar4100","volume":"14","author":"R Liu","year":"2012","unstructured":"Liu R, Wu Q, Su D, Che N, Chen H, Geng L, et al. A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis. Arthritis Res Ther. 2012;14:R255.","journal-title":"Arthritis Res Ther"},{"key":"1086_CR12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/cei.12162","volume":"174","author":"J Wang","year":"2013","unstructured":"Wang J, Shan Y, Jiang Z, Feng J, Li C, Ma L, et al. High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis. Clin Exp Immunol. 2013;174:212\u201320.","journal-title":"Clin Exp Immunol"},{"key":"1086_CR13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/art.27222","volume":"62","author":"AK Maiti","year":"2010","unstructured":"Maiti AK, Kim-Howard X, Viswanathan P, Guillen L, Rojas-Villarraga A, Deshmukh H, et al. Confirmation of an association between rs6822844 at the Il2-Il21 region and multiple autoimmune diseases: evidence of a general susceptibility locus. Arthritis Rheum. 2010;62:323\u20139.","journal-title":"Arthritis Rheum"},{"key":"1086_CR14","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/art.1780331006","volume":"33","author":"K Terato","year":"1990","unstructured":"Terato K, Shimozuru Y, Katayama K, Takemitsu Y, Yamashita I, Miyatsu M, et al. Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum. 1990;33:1493\u2013500.","journal-title":"Arthritis Rheum"},{"key":"1086_CR15","first-page":"589","volume":"27","author":"X He","year":"2000","unstructured":"He X, Kang AH, Stuart JM. Accumulation of T cells reactive to type II collagen in synovial fluid of patients with rheumatoid arthritis. J Rheumatol. 2000;27:589\u201393.","journal-title":"J Rheumatol"},{"key":"1086_CR16","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/eji.1830240736","volume":"24","author":"U Brunsberg","year":"1994","unstructured":"Brunsberg U, Gustafsson K, Jansson L, Michaelsson E, Ahrlund-Richter L, Pettersson S, et al. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol. 1994;24:1698\u2013702.","journal-title":"Eur J Immunol"},{"key":"1086_CR17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1084\/jem.154.3.688","volume":"154","author":"PH Wooley","year":"1981","unstructured":"Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med. 1981;154:688\u2013700.","journal-title":"J Exp Med"},{"key":"1086_CR18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.162.3.1105","volume":"162","author":"GE Ranges","year":"1985","unstructured":"Ranges GE, Sriram S, Cooper SM. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med. 1985;162:1105\u201310.","journal-title":"J Exp Med"},{"key":"1086_CR19","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R","volume":"30","author":"IK Campbell","year":"2000","unstructured":"Campbell IK, Hamilton JA, Wicks IP. Collagen-induced arthritis in C57BL\/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol. 2000;30:1568\u201375.","journal-title":"Eur J Immunol"},{"key":"1086_CR20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-2249.1998.00529.x","volume":"111","author":"L Svensson","year":"1998","unstructured":"Svensson L, Jirholt J, Holmdahl R, Jansson L. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol. 1998;111:521\u20136.","journal-title":"Clin Exp Immunol"},{"key":"1086_CR21","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","volume":"171","author":"S Nakae","year":"2003","unstructured":"Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 2003;171:6173\u20137.","journal-title":"J Immunol"},{"key":"1086_CR22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.20001","volume":"50","author":"E Lubberts","year":"2004","unstructured":"Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004;50:650\u20139.","journal-title":"Arthritis Rheum"},{"key":"1086_CR23","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/art.22452","volume":"56","author":"DA Young","year":"2007","unstructured":"Young DA, Hegen M, Ma HL, Whitters MJ, Albert LM, Lowe L, et al. Blockade of the interleukin-21\/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum. 2007;56:1152\u201363.","journal-title":"Arthritis Rheum"},{"key":"1086_CR24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.imlet.2014.09.007","volume":"163","author":"JG Ryu","year":"2015","unstructured":"Ryu JG, Lee J, Kim EK, Seo HB, Park JS, Lee SY, et al. Treatment of IL-21R-Fc control autoimmune arthritis via suppression of STAT3 signal pathway mediated regulation of the Th17\/Treg balance and plasma B cells. Immunol Lett. 2015;163:143\u201350.","journal-title":"Immunol Lett"},{"key":"1086_CR25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm1292","volume":"11","author":"M Frentsch","year":"2005","unstructured":"Frentsch M, Arbach O, Kirchhoff D, Moewes B, Worm M, Rothe M, et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med. 2005;11:1118\u201324.","journal-title":"Nat Med"},{"key":"1086_CR26","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.4049\/jimmunol.1301173","volume":"191","author":"KE Block","year":"2013","unstructured":"Block KE, Huang H. The cellular source and target of IL-21 in K\/BxN autoimmune arthritis. J Immunol. 2013;191:2948\u201355.","journal-title":"J Immunol"},{"key":"1086_CR27","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.4049\/jimmunol.0804350","volume":"182","author":"E Jang","year":"2009","unstructured":"Jang E, Cho SH, Park H, Paik DJ, Kim JM, Youn J. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4\u2009+\u2009CD25\u2013 T cell expansion is essential for the development of arthritis in autoimmune K\/BxN mice. J Immunol. 2009;182:4649\u201356.","journal-title":"J Immunol"},{"key":"1086_CR28","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.4049\/jimmunol.1300439","volume":"191","author":"CG McPhee","year":"2013","unstructured":"McPhee CG, Bubier JA, Sproule TJ, Park G, Steinbuck MP, Schott WH, et al. IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB.Yaa mice. J Immunol. 2013;191:4581\u20138.","journal-title":"J Immunol"},{"key":"1086_CR29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8:967\u201374.","journal-title":"Nat Immunol"},{"key":"1086_CR30","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/eji.200838511","volume":"38","author":"I Sonderegger","year":"2008","unstructured":"Sonderegger I, Kisielow J, Meier R, King C, Kopf M. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur J Immunol. 2008;38:1833\u20138.","journal-title":"Eur J Immunol"},{"key":"1086_CR31","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.4049\/jimmunol.180.11.7097","volume":"180","author":"JM Coquet","year":"2008","unstructured":"Coquet JM, Chakravarti S, Smyth MJ, Godfrey DI. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J Immunol. 2008;180:7097\u2013101.","journal-title":"J Immunol"},{"key":"1086_CR32","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/1529-0131(199812)41:12<2117::AID-ART6>3.0.CO;2-P","volume":"41","author":"N Takagi","year":"1998","unstructured":"Takagi N, Mihara M, Moriya Y, Nishimoto N, Yoshizaki K, Kishimoto T, et al. Blockade of interleukin-6 receptor ameliorates joint disease in murine coaagen-induced arthritis. Arthritis Rheum. 1998;41:2117\u201321.","journal-title":"Arthritis Rheum"},{"key":"1086_CR33","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.4049\/jimmunol.0903949","volume":"184","author":"J Bessa","year":"2010","unstructured":"Bessa J, Kopf M, Bachmann MF. Cutting edge: IL-21 and TLR signaling regulate germinal center responses in a B cell-intrinsic manner. J Immunol. 2010;184:4615\u20139.","journal-title":"J Immunol"},{"key":"1086_CR34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","volume":"29","author":"S Crotty","year":"2011","unstructured":"Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29:621\u201363.","journal-title":"Annu Rev Immunol"},{"key":"1086_CR35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ni.1704","volume":"10","author":"N Fazilleau","year":"2009","unstructured":"Fazilleau N, McHeyzer-Williams LJ, Rosen H, McHeyzer-Williams MG. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat Immunol. 2009;10:375\u201384.","journal-title":"Nat Immunol"},{"key":"1086_CR36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5414\/CP202474","volume":"54","author":"S Ignatenko","year":"2016","unstructured":"Ignatenko S, Skrumsager BK, Mouritzen U. Safety, PK, and PD of recombinant anti-interleukin-21 monoclonal antibody in a first-in-human trial. Int J Clin Pharmacol Ther. 2016;54:243\u201352.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1086_CR37","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/art.33489","volume":"64","author":"P Suwannalai","year":"2012","unstructured":"Suwannalai P, van de Stadt LA, Radner H, Steiner G, El-Gabalawy HS, Zijde CM, et al. Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum. 2012;64:1323\u20138.","journal-title":"Arthritis Rheum"},{"key":"1086_CR38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kev347","volume":"55","author":"DM Gerlag","year":"2016","unstructured":"Gerlag DM, Norris JM, Tak PP. Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventiive treatment. Rheumatology. 2016;55:607\u201314.","journal-title":"Rheumatology"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1086-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T03:53:26Z","timestamp":1657079606000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1086-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,17]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1086-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,17]]},"article-number":"188"}}